HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Warner, T T Articles by Schapira, A H V Search for Related Content PubMed PubMed Citation Articles by Warner, T T Articles by Schapira, A H V

J Neurol Neurosurg Psychiatry 1998;65:378-379 ( September )

Short report

The role of the -synuclein gene mutation in patients with sporadic Parkinson's disease in the United Kingdom T T Warner, A H V Schapira

University Department of Clinical Neurosciences, Royal Free Hospital School of Medicine, Rowland Hill Street, London, UK

Correspondence to: Dr T T Warner, University Department of Clinical Neurosciences, Royal Free Hospital School of Medicine, Rowland Hill Street, London NW3 2PF, UK.

Received 21 November 1997 and in revised form 9 February 1998; Accepted 16 February

Parkinson's disease is a common neurodegenerative disorder of unknown aetiology. A pathogenic point mutation within the -synuclein gene has recently been identified in one Italian-American kindred and three families of Greek origin with parkinsonism. DNA from 70 patients with Parkinson's disease was screened for this G209A mutation. No samples were positive for the mutation, suggesting that it is not relevant for most patients with sporadic idiopathic Parkinson's disease.

Keywords: Parkinson's disease; -synuclein gene

---

© 1998 by Journal of Neurology, Neurosurgery, and Psychiatry

This article has been cited by other articles:

				A.H. V. Schapira Neuroprotection in PD--A role for dopamine agonists? Neurology, September 23, 2003; 61(90063): S34 - 42. [Full Text]

				M. C. J. Dekker, V. Bonifati, and C. M. van Duijn Parkinson's disease: piecing together a genetic jigsaw Brain, August 1, 2003; 126(8): 1722 - 1733. [Abstract] [Full Text] [PDF]

				A. H. V. Schapira Neuroprotection and dopamine agonists Neurology, February 1, 2002; 58(90001): S9 - 18. [Abstract] [Full Text]

				R. J. Perrin, W. S. Woods, D. F. Clayton, and J. M. George Exposure to Long Chain Polyunsaturated Fatty Acids Triggers Rapid Multimerization of Synucleins J. Biol. Chem., November 2, 2001; 276(45): 41958 - 41962. [Abstract] [Full Text] [PDF]

				S. J. Tabrizi, M. Orth, J. M. Wilkinson, J.-W. Taanman, T. T. Warner, J. M. Cooper, and A. H.V. Schapira Expression of mutant {alpha}-synuclein causes increased susceptibility to dopamine toxicity Hum. Mol. Genet., November 1, 2000; 9(18): 2683 - 2689. [Abstract] [Full Text] [PDF]